ivabradine has been researched along with Disease Exacerbation in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ako, J; Hagiwara, N; Inomata, T; Ito, H; Kawasaki, Y; Kihara, Y; Momomura, SI; Saito, Y; Sakata, Y; Shimokawa, H; Tanaka, T; Tsutsui, H; Yamamoto, K; Yamashina, A; Yano, M | 1 |
| Bekele, T; Hailu, A; Mengesha, HG; Otieno, MG; Petrucka, P; Weldearegawi, B | 1 |
| Abrahamsson, P; Böhm, M; Borer, JS; Ford, I; Kober, L; Komajda, M; Lloyd, SM; Metra, M; Swedberg, K; Tavazzi, L | 1 |
| Böhm, M; Borer, JS; Ford, I; Komajda, M; Robertson, M; Swedberg, K; Tavazzi, L | 1 |
| Einecke, D | 1 |
| Alexopoulos, D; Apostolakis, E; Hahalis, G; Koniari, I; Mavrilas, D; Papadaki, H; Papadimitriou, E; Papalois, A; Poimenidi, E; Xanthopoulou, I | 1 |
| Böhm, M; Borer, JS; Ford, I; Komajda, M; Moyne, A; Swedberg, K; Tavazzi, L | 1 |
| D'Ettorre, E; De Benedittis, G; de Gregorio, C; Della Rosa, G; Distante, A; Piscitelli, P | 1 |
| Dolgikh, VT; Kondrat'ev, AI; Stotskiĭ, AO | 1 |
| Ferrari, R; Fox, KM | 1 |
| Lopatin, IuM | 1 |
| Bolduc, V; Des Rosiers, C; Drouin, A; Duquette, N; Frayne-Robillard, I; Gillis, MA; Tardif, JC; Thorin, E; Thorin-Trescases, N | 1 |
| Francis, GS; Sarraf, M | 1 |
| Böhm, M; Borer, J; Ford, I; Gonzalez-Juanatey, JR; Komajda, M; Lopez-Sendon, J; Reil, JC; Swedberg, K; Tavazzi, L | 1 |
| Aalbers, J | 1 |
| Deedwania, PC | 1 |
4 review(s) available for ivabradine and Disease Exacerbation
| Article | Year |
|---|---|
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials.
Topics: Aged; Angina, Stable; Benzazepines; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Disease Progression; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2017 |
Heart rate: a forgotten link in coronary artery disease?
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Arteriosclerosis; Benzazepines; Coronary Artery Disease; Coronary Vessels; Disease Progression; Elasticity; Endothelium, Vascular; Heart Rate; Hemodynamics; Humans; Ivabradine; Myocardial Ischemia; Myocardium; Oxygen Consumption | 2011 |
[From results of BEAUTIFUL trial to results of SHIFT trial: BEAUTIFUL possibility to make a SHIFT in current guidelines].
Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Cyclic Nucleotide-Gated Cation Channels; Disease Progression; Evidence-Based Medicine; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2011 |
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2012 |
5 trial(s) available for ivabradine and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study.
Topics: Aged; Cardiovascular Agents; Cause of Death; Chronic Disease; Disease Progression; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Japan; Male; Middle Aged; Patient Admission; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2019 |
Risk following hospitalization in stable chronic systolic heart failure.
Topics: Aged; Aged, 80 and over; Benzazepines; Cardiovascular Agents; Chronic Disease; Disease Progression; Female; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Time Factors | 2013 |
Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study).
Topics: Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heart Failure, Systolic; Humans; Ivabradine; Male; Middle Aged; Prognosis; Prospective Studies; Severity of Illness Index; Treatment Outcome; Ventricular Function, Left | 2014 |
Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
Topics: Aged; Benzazepines; Cardiovascular Agents; Disease Progression; Double-Blind Method; Female; Heart Failure, Systolic; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Patient Readmission; Treatment Outcome | 2016 |
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
Topics: Aged; Anti-Arrhythmia Agents; Benzazepines; Chronic Disease; Disease Progression; Double-Blind Method; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Patient Selection; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2013 |
7 other study(ies) available for ivabradine and Disease Exacerbation
| Article | Year |
|---|---|
[SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].
Topics: Benzazepines; Cause of Death; Coronary Disease; Disease Progression; Humans; Ivabradine; Randomized Controlled Trials as Topic; Survival Analysis | 2014 |
Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta's Stiffness in Hypercholesterolemic Rabbits.
Topics: Animals; Antioxidants; Aorta, Thoracic; Aortic Diseases; Atherosclerosis; Benzazepines; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperplasia; Ivabradine; Male; Neointima; Oxidative Stress; Plaque, Atherosclerotic; Rabbits; Simvastatin; Vascular Stiffness | 2016 |
Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure?
Topics: Adult; Benzazepines; Cardiomyopathy, Dilated; Cardiovascular Agents; Disease Progression; Heart Failure; Humans; Ivabradine; Male; Muscular Dystrophy, Duchenne; Treatment Outcome | 2016 |
[Efficacy of ivabradine in combination therapy for complicated acute coronary syndrome in patients with type 2 diabetes mellitus].
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Benzazepines; Diabetes Mellitus, Type 2; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Hypoglycemic Agents; Ivabradine; Male; Metoprolol; Middle Aged; Treatment Outcome; Ventricular Function, Left | 2010 |
Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice.
Topics: Animals; Anti-Arrhythmia Agents; Apolipoproteins B; Atherosclerosis; Benzazepines; Carotid Arteries; Carotid Artery Diseases; Cerebral Arteries; Cerebrovascular Disorders; Compliance; Disease Models, Animal; Disease Progression; Dyslipidemias; Endothelium, Vascular; Exercise Therapy; Genotype; Heart Rate; Humans; Ivabradine; Male; Matrix Metalloproteinase 9; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase Type III; Phenotype; Receptors, LDL; Severity of Illness Index; Stress, Mechanical; Time Factors; Vasodilation | 2011 |
Ivabradine reduces total hospital burden in heart failure.
Topics: Benzazepines; Disease Progression; Disease-Free Survival; Health Care Costs; Heart Failure; Heart Rate; Hospitalization; Humans; Ivabradine; Length of Stay; Practice Guidelines as Topic | 2012 |
Ivabradine in heart failure: hope or hype?
Topics: Adrenergic beta-Antagonists; Benzazepines; Cardiotonic Agents; Cyclic Nucleotide-Gated Cation Channels; Disease Progression; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Heart Rate; Humans; Ivabradine; Membrane Transport Modulators | 2012 |